THORLNC and cancer: TCGA and CHUAlgarve cohorts, revealed that THOR was significantly hypermethylated in malignant breast tissue when compared to benign tissue, distinguishing cancer from normal tissue from the earliest stage of disease (AUC > 0.9574; P < 0.0001).